Targeting Polo-Like Kinase 1, a Regulator of P53, in the Treatment of Adrenocortical Carcinoma
Clinical and Translational Medicine - United Kingdom
doi 10.1186/s40169-015-0080-3
Full Text
Open PDFAbstract
Available in full text
Date
January 11, 2016
Authors
Publisher
Springer Science and Business Media LLC